Cox-2 inhibitors in the treatment of small cell lung cancer patients

Efimia Boutsikou (Thessaloniki, Greece), Efimia Boutsikou, Paul Zarogoulidis, Tania Konstanta, Sofia Lampaki, Lefteris Vlogiaris, Dionisis Spyratos, Konstantinos Zarogoulidis

Source: International Congress 2015 – Advances in the therapy of lung cancer
Session: Advances in the therapy of lung cancer
Session type: Oral Presentation
Number: 268
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Efimia Boutsikou (Thessaloniki, Greece), Efimia Boutsikou, Paul Zarogoulidis, Tania Konstanta, Sofia Lampaki, Lefteris Vlogiaris, Dionisis Spyratos, Konstantinos Zarogoulidis. Cox-2 inhibitors in the treatment of small cell lung cancer patients. Eur Respir J 2015; 46: Suppl. 59, 268

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

The active compound of garlic to treat non-small cell lung cancer: in vitro studies
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Glucocorticoid reduces pemetrexed sensitivity by mediating senescence-associated secretory phenotype in Bcl-2 dependent manner in non-small-cell lung cancer
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013

Antitumor efficacy of the double suicide genesin lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Outcomes of radical treatment of early stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Functional impairment of NK cells in non-small-cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Surgical treatmment non-small cell lung cancer in the elderly patients
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Multiple primary malignancies in Japanese patients with non-small cell lung cancer
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013

The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014